These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15069328)

  • 21. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
    Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
    Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
    Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
    J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG-PET in adrenocortical carcinoma.
    Becherer A; Vierhapper H; Pötzi C; Karanikas G; Kurtaran A; Schmaljohann J; Staudenherz A; Dudczak R; Kletter K
    Cancer Biother Radiopharm; 2001 Aug; 16(4):289-95. PubMed ID: 11602999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High False Positivity in Positron Emission Tomography is a Potential Diagnostic Pitfall in Patients with Suspected Adrenal Metastasis.
    Lang BH; Cowling BJ; Li JY; Wong KP; Wan KY
    World J Surg; 2015 Aug; 39(8):1902-8. PubMed ID: 25809060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-body positron emission tomographic scanning in patients with adrenal cortical carcinoma: comparison with conventional imaging procedures.
    Ahmed M; Al-Sugair A; Alarifi A; Almahfouz A; Al-Sobhi S
    Clin Nucl Med; 2003 Jun; 28(6):494-7. PubMed ID: 12917534
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adrenal cortical adenoma with increased uptake of 18F-fluoro-deoxy-glucose on PET/CT suspected as an adrenal metastasis from the cervical cancer : a case report].
    Takemura M; Izaki H; Komori M; Senzaki T; Fukawa T; Yamamoto Y; Yamaguchi K; Nakatsuji H; Takahashi M; Fukumori T; Kanayama HO
    Hinyokika Kiyo; 2013 Feb; 59(2):91-5. PubMed ID: 23552750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary adenomas can appear as hypermetabolic lesions in (18) F-FDG PET imaging.
    Ryu SI; Tafti BA; Skirboll SL
    J Neuroimaging; 2010 Oct; 20(4):393-6. PubMed ID: 19453834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
    Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
    J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate.
    Bergström M; Juhlin C; Bonasera TA; Sundin A; Rastad J; Akerström G; Långström B
    J Nucl Med; 2000 Feb; 41(2):275-82. PubMed ID: 10688111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Imaging of an adrenal cortex carcinoma and its metastasis with FDG-PET].
    Schumacher T; Brink I; Moser E; Nitzsche EU
    Nuklearmedizin; 1999; 38(4):124-6. PubMed ID: 10392378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A Case of 18FDG PET/CT-Positive Adrenal Adenoma Suspected of Being Adrenal Metastasis of Synchronous Triple Cancer].
    Tani M; Abe T; Fukuhara S; Fujita K; Uemura M; Kiuchi H; Imamura R; Nonomura N
    Hinyokika Kiyo; 2020 Mar; 66(3):77-80. PubMed ID: 32316702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gallium-67 uptake by a benign adrenocortical adenoma.
    Jackson JA; Naul LG; Montgomery JL; Carpentier WR; Roberts JW
    J Nucl Med; 1988 Aug; 29(8):1451-3. PubMed ID: 3261335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of 18F-FDG-positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients].
    Pavón-Paz I; Rosado-Sierra JA; Balsa-Bretón MÁ; Guijarro-Armas G; Merino-Viveros M; Penín-Gonzalez FJ
    Med Clin (Barc); 2016 Feb; 146(3):104-7. PubMed ID: 26343158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging features of atypical adrenocortical adenomas: a radiological-pathological correlation.
    Gargan ML; Lee E; O'Sullivan M; Egan M; Gibney J; Crowther S; Conlon K; Feeney J
    Br J Radiol; 2022 Jan; 95(1129):20210642. PubMed ID: 34735299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning.
    Han SJ; Kim TS; Jeon SW; Jeong SJ; Yun M; Rhee Y; Kang ES; Cha BS; Lee EJ; Lee HC; Lim SK
    Int J Clin Pract; 2007 May; 61(5):802-9. PubMed ID: 17343665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease.
    Libé R; Jazeron JF; Louiset E; Groussin L
    Endocrine; 2019 Jan; 63(1):188-189. PubMed ID: 30251165
    [No Abstract]   [Full Text] [Related]  

  • 39. Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy.
    Libé R; Tissier F; Bienvenu M; Groussin L; Joannidis S; Hignette C; Dousset B; Legmann P; Faraggi M; Richard B; Bertagna X; Tenenbaum F
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3631-2. PubMed ID: 19808858
    [No Abstract]   [Full Text] [Related]  

  • 40. Adrenal-to-liver SUV ratio is the best parameter for differentiation of adrenal metastases from adenomas using 18F-FDG PET/CT.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Kawada H; Noda Y; Moriyama N
    Ann Nucl Med; 2013 Aug; 27(7):648-53. PubMed ID: 23625579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.